Mental Health and Sexuality in Adolescents and Young Adults (SEX-T-ADO)

September 4, 2025 updated by: Fondation Santé des Étudiants de France

According to the World Health Organization (WHO), "Sexual health is a state of physical, emotional, mental and social well-being in relation to sexuality, not merely the absence of disease, dysfunction or of infirmity. Sexual health requires a positive and respectful approach to sexuality and sexual relationships [...]".

The main objective is to show that a training intervention intended for psychiatric care teams and targeted on the question of the impact of psychiatric disorders and psychotropic drugs on the sexuality of young people, increases the proportion of young people with whom the question of sexual health is discussed (in connection with psychiatric disorders and, if applicable, with the taking of psychotropic treatment, while they are hospitalized for a psychiatric disorder in the clinics of the FSEF and receive, or not, psychotropic treatment ).

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

Non-interventional multicenter prospective mixed study (quantitative and qualitative).

Research process in 3 phases:

  1. Inventory with a mixed method evaluation (quantitative survey and qualitative survey),

    • Step 1: quantitative survey with self-administered questionnaire offered to all patients attending psychiatric study care during the month of the assessment.
    • Step 2: qualitative survey of young people and caregivers.
  2. Design and implementation of an intervention adapted to the needs of the field (training for caregivers and tools for young people).

    • Step 3: implementation of training programs for professionals based on data from phase 1 and preparation for interventions for young people.
    • Step 4: Interventions (interventions with young people in groups and individually).
  3. Reassessment after the deployment of the intervention - Step 5: Finally, the quantitative survey of stage 1 with a self-questionnaire offered to all patients present in psychiatric care-study will be repeated during one month of the evaluation in order to measure the impact of the action taken.

Study Type

Observational

Enrollment (Estimated)

770

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Alpes Maritimes
      • Vence, Alpes Maritimes, France, 06140
        • Recruiting
        • Clinique FSEF Vence
    • Auvergne-Rhône-Alpes
      • Grenoble, Auvergne-Rhône-Alpes, France, 38700
        • Recruiting
        • Clinique FSEF Grenoble La Tronche
    • Brittany Region
      • Rennes, Brittany Region, France, 35700
        • Recruiting
        • Clinique FSEF Rennes-Beaulieu
    • Landes
      • Aire-sur-l'Adour, Landes, France, 40800
        • Recruiting
        • Clinique FSEF Aire sur l'Adour
    • Marne
      • Vitry-le-François, Marne, France, 51300
        • Recruiting
        • Clinique FSEF Vitry-le-François
    • Nord
      • Villeneuve-d'Ascq, Nord, France, 59650
        • Recruiting
        • Clinique FSEF Villeneuve d'Ascq
    • Pays de la Loire Region
      • Sablé-sur-Sarthe, Pays de la Loire Region, France, 72300
        • Recruiting
        • Clinique FSEF Sablé-sur-Sarthe
    • Île-de-France Region
      • Bouffémont, Île-de-France Region, France, 95570
        • Recruiting
        • Clinique FSEF Bouffémont
      • Neufmoutiers-en-Brie, Île-de-France Region, France, 77610
        • Recruiting
        • Clinique FSEF Neufmoutiers-en-Brie
      • Paris, Île-de-France Region, France, 75013
        • Recruiting
        • Clinique FSEF Paris 13
      • Paris, Île-de-France Region, France, 75016
        • Recruiting
        • Clinique FSEF Paris 16
      • Sceaux, Île-de-France Region, France, 92330
        • Recruiting
        • Clinique FSEF Sceaux

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

15 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

All young people hospitalized in the 13 structures of the FSEF aged 15 or over.

Description

Inclusion Criteria:

  • Young people hospitalized in psychiatric care-studies in one of the establishments of the FSEF,
  • Age ≥ 15 years (age of sexual majority),
  • Receiving or not a psychotropic treatment,
  • No opposition to participation (or parents for minors) in the study and use of data

Exclusion Criteria:

  • Refusal to participate
  • Patient under 15 years old
  • Need for emergency care (medicine or psychiatry).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Comparison
Time Frame: self-questionnaire after the team training (T2 = 1 year)
To show that a training intervention intended for the healthcare team makes it possible to increase the proportion of young people with whom the question of sexual health has been approached, in connection with psychiatric disorders and, if necessary, with taking treatment psychotropics; while they are hospitalized for a psychiatric disorder in the clinics of the FSEF and receive, or not, a psychotropic treatment.
self-questionnaire after the team training (T2 = 1 year)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Description
Time Frame: self-questionnaire (T0 = within three months of the opening of the center)
Describe the sexuality of adolescents and young adults hospitalized in a psychiatric establishment within the FSEF with quantitative survey with self-questionnaire exploring sexual adverse effects
self-questionnaire (T0 = within three months of the opening of the center)
Comparison
Time Frame: self-questionnaire (T0 = within three months of the opening of the center)
To compare the sexual life of patients hospitalized at the FSEF for a psychiatric illness - according to whether or not they receive psychotropic treatment with quantitative survey with self-questionnaire exploring sexual adverse effects
self-questionnaire (T0 = within three months of the opening of the center)
Comparison
Time Frame: self-questionnaire after the team training (T2 = 1 year)
To compare the perceived impact of psychiatric disorders and psychotropic treatments on patients' sexual satisfaction measured by a Likert scale of sexual satisfaction (rated from 1 to 5 with 1 equal to very satisfied and 5 to very dissatisfied) before and after intervention.
self-questionnaire after the team training (T2 = 1 year)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 27, 2023

Primary Completion (Estimated)

November 1, 2025

Study Completion (Estimated)

November 1, 2025

Study Registration Dates

First Submitted

March 17, 2022

First Submitted That Met QC Criteria

April 6, 2022

First Posted (Actual)

April 7, 2022

Study Record Updates

Last Update Posted (Estimated)

September 5, 2025

Last Update Submitted That Met QC Criteria

September 4, 2025

Last Verified

August 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 2021-A03080-41

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Psychiatric Disorder

Clinical Trials on self-questionnaire

Subscribe